Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
08 07 2021
Historique:
received: 24 09 2020
revised: 10 04 2021
accepted: 14 05 2021
pubmed: 25 6 2021
medline: 4 1 2022
entrez: 24 6 2021
Statut: ppublish

Résumé

The microbiota plays a fundamental role in regulating host immunity. However, the processes involved in the initiation and regulation of immunity to the microbiota remain largely unknown. Here, we show that the skin microbiota promotes the discrete expression of defined endogenous retroviruses (ERVs). Keratinocyte-intrinsic responses to ERVs depended on cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes protein (STING) signaling and promoted the induction of commensal-specific T cells. Inhibition of ERV reverse transcription significantly impacted these responses, resulting in impaired immunity to the microbiota and its associated tissue repair function. Conversely, a lipid-enriched diet primed the skin for heightened ERV- expression in response to commensal colonization, leading to increased immune responses and tissue inflammation. Together, our results support the idea that the host may have co-opted its endogenous virome as a means to communicate with the exogenous microbiota, resulting in a multi-kingdom dialog that controls both tissue homeostasis and inflammation.

Identifiants

pubmed: 34166614
pii: S0092-8674(21)00650-4
doi: 10.1016/j.cell.2021.05.020
pmc: PMC8381240
pii:
doi:

Substances chimiques

Interferon Type I 0
Membrane Proteins 0
Retroelements 0
Sting1 protein, mouse 0
Nucleotidyltransferases EC 2.7.7.-
cGAS protein, mouse EC 2.7.7.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3794-3811.e19

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : Cancer Research UK
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102898/B/13/Z
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests Y.B. is a member of the advisory board of the journal Cell.

Références

Immunity. 2015 May 19;42(5):953-964
pubmed: 25992864
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):E5699-705
pubmed: 26371324
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8367-72
pubmed: 26100872
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Science. 2013 Aug 23;341(6148):903-6
pubmed: 23929945
Front Immunol. 2020 Nov 13;11:593891
pubmed: 33281822
Nat Protoc. 2008;3(5):799-810
pubmed: 18451788
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Cell. 2016 Jan 28;164(3):337-40
pubmed: 26824647
PLoS Pathog. 2012;8(5):e1002709
pubmed: 22589728
Nat Rev Immunol. 2016 Apr;16(4):207-19
pubmed: 27026073
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16465-16474
pubmed: 32601220
Cell. 2020 May 28;181(5):1080-1096.e19
pubmed: 32380006
Science. 2019 Jan 4;363(6422):
pubmed: 30523076
Nat Rev Endocrinol. 2017 Nov;13(11):633-643
pubmed: 28799554
Cell Stem Cell. 2011 Jun 3;8(6):676-87
pubmed: 21624812
Cell Rep. 2019 Jul 2;28(1):245-256.e4
pubmed: 31269444
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23643-23652
pubmed: 31672911
Science. 1998 Nov 27;282(5394):1669-75
pubmed: 9831551
Nature. 2019 Jan;565(7741):600-605
pubmed: 30675064
Science. 2012 Aug 31;337(6098):1115-9
pubmed: 22837383
Science. 2012 Sep 21;337(6101):1553-6
pubmed: 22923434
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19256-61
pubmed: 19889972
Science. 2016 Feb 26;351(6276):aad4234
pubmed: 26917774
Genome Biol. 2014;15(12):550
pubmed: 25516281
PLoS Pathog. 2020 May 26;16(5):e1008605
pubmed: 32453763
Nucleic Acids Res. 2017 Jan 4;45(D1):D68-D73
pubmed: 27924012
PLoS One. 2014 Mar 24;9(3):e92753
pubmed: 24663492
Cell. 2018 Feb 8;172(4):784-796.e18
pubmed: 29358051
Database (Oxford). 2016 May 30;2016:
pubmed: 27242033
J Virol. 2012 Jan;86(1):630-4
pubmed: 22013053
Cell Chem Biol. 2019 Aug 15;26(8):1095-1109.e14
pubmed: 31155508
Nature. 2015 Apr 2;520(7545):104-8
pubmed: 25539086
Nature. 2018 Jan 24;553(7689):427-436
pubmed: 29364286
Nature. 2012 Nov 29;491(7426):774-8
pubmed: 23103862
Science. 2002 Apr 12;296(5566):301-5
pubmed: 11951032
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Virology. 2019 Jan 2;526:52-60
pubmed: 30342302
J Exp Med. 2018 Mar 5;215(3):785-799
pubmed: 29382696
Annu Rev Virol. 2015 Nov;2(1):135-59
pubmed: 26958910
Cell Syst. 2016 Sep 28;3(3):221-237.e9
pubmed: 27641957
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Genes Dev. 2011 Mar 15;25(6):594-607
pubmed: 21357675
Sci Transl Med. 2017 Jul 5;9(397):
pubmed: 28679656
PLoS Genet. 2015 Jul 02;11(7):e1005367
pubmed: 26134849
Annu Rev Immunol. 2017 Apr 26;35:313-336
pubmed: 28142323
Nature. 2014 Jun 5;510(7503):152-6
pubmed: 24739972
FASEB J. 2008 Mar;22(3):659-61
pubmed: 17942826
Nat Rev Microbiol. 2012 May 08;10(6):395-406
pubmed: 22565131
Immunity. 2012 Jul 27;37(1):158-70
pubmed: 22705104
Front Microbiol. 2017 Dec 12;8:2489
pubmed: 29312197
J Invest Dermatol. 2014 Jul;134(7):1828-1838
pubmed: 24441097
Nat Immunol. 2017 Jul 19;18(8):851-860
pubmed: 28722709
Cancer Lett. 2011 Dec 8;311(2):171-6
pubmed: 21852035
Cell. 2016 Nov 17;167(5):1323-1338.e14
pubmed: 27863246
Immunity. 2019 Apr 16;50(4):907-923
pubmed: 30995506
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12565-12572
pubmed: 30455304
J Virol. 2009 Aug;83(16):8254-8
pubmed: 19494021
Science. 2019 Oct 25;366(6464):
pubmed: 31649166
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Cell. 2015 Oct 8;163(2):381-93
pubmed: 26411290
J Virol. 1990 Dec;64(12):6176-83
pubmed: 1700832
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Immunol. 2020 Sep;21(9):1034-1045
pubmed: 32661363
J Immunol. 2009 Jun 15;182(12):8094-103
pubmed: 19494335
Retrovirology. 2014 Jul 25;11:59
pubmed: 25063042
Science. 2017 Aug 4;357(6350):498-502
pubmed: 28774928
Mol Cell Biol. 2001 Jan;21(2):467-75
pubmed: 11134335
Nat Med. 2007 Jul;13(7):843-50
pubmed: 17558415
Nat Immunol. 2017 Feb;18(2):225-235
pubmed: 28024153
J Exp Med. 2016 Mar 7;213(3):329-36
pubmed: 26880576
Front Immunol. 2018 Jan 15;8:1970
pubmed: 29379506
Genome Biol. 2018 Dec 19;19(1):224
pubmed: 30567574
Immunity. 2017 Apr 18;46(4):562-576
pubmed: 28423337
Indian J Dermatol. 2013 Jul;58(4):299-305
pubmed: 23919003
Microbiol Spectr. 2015 Apr;3(2):MDNA3-0027-2014
pubmed: 26104704
Cell. 2008 Aug 22;134(4):587-98
pubmed: 18724932
Gut Microbes. 2020 Jul 3;11(4):771-788
pubmed: 31941397
Genes Dev. 1997 Nov 1;11(21):2910-24
pubmed: 9353259
Annu Rev Virol. 2018 Sep 29;5(1):341-362
pubmed: 30265633
Cell. 2015 Aug 27;162(5):974-86
pubmed: 26317466

Auteurs

Djalma S Lima-Junior (DS)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Siddharth R Krishnamurthy (SR)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Nicolas Bouladoux (N)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Nicholas Collins (N)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Seong-Ji Han (SJ)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Erin Y Chen (EY)

Department of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA.

Michael G Constantinides (MG)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Verena M Link (VM)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; NIH Center for Human Immunology, Bethesda, MD 20896, USA.

Ai Ing Lim (AI)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Michel Enamorado (M)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Christophe Cataisson (C)

In Vitro Pathogenesis Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Louis Gil (L)

NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Indira Rao (I)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA.

Taylor K Farley (TK)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Roosevelt Drive, Oxford OX3 7FY, UK.

Galina Koroleva (G)

NIH Center for Human Immunology, Bethesda, MD 20896, USA.

Jan Attig (J)

Retroviral Immunology, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Medicine, Faculty of Medicine, Imperial College London, London W2 1PG, UK.

Stuart H Yuspa (SH)

In Vitro Pathogenesis Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Michael A Fischbach (MA)

Department of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA.

George Kassiotis (G)

Retroviral Immunology, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Medicine, Faculty of Medicine, Imperial College London, London W2 1PG, UK.

Yasmine Belkaid (Y)

Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: ybelkaid@niaid.nih.gov.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH